Breaking: Government Trial Shows Efficacy for Remdesivir in COVID Infection

A placebo-controlled, government run trial of remdesivir to treat COVID-19 infection reportedly met its “primary efficacy endpoint” according to Gilead Sciences. While we are waiting for more information on the results, having shown efficacy in this large (800 patient), controlled trial could help to resolve the questions raised in prior testing of the drug.

More to come….

Published by jbakerjrblog

Immunologist, former Army MD, former head of allergy and clinical immunology at University of Michigan, vaccine developer and opinionated guy.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: